Global risk assessment of aflatoxins in maize and peanuts: Are regulatory standards adequately protective?

Toxicological Sciences

Volumn 135, Issue 1, 2013, Pages 251-259

  Wu, Felicia ^a   Stacy, Shaina L ^b   Kensler, Thomas W ^c  

^a Michigan State University   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

(3 6) aflatoxin; Hepatocellular carcinoma; Risk assessment

Indexed keywords

AFLATOXIN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CANCER RISK; FOOD INTAKE; HEPATITIS B; LIVER CELL CARCINOMA; MAIZE; PEANUT; PREVALENCE; RISK ASSESSMENT; SEROPREVALENCE;

(3-6) AFLATOXIN; HEPATOCELLULAR CARCINOMA; RISK ASSESSMENT.;

AFLATOXINS; ARACHIS HYPOGAEA; CARCINOMA, HEPATOCELLULAR; FOOD SAFETY; HEPATITIS B; HUMANS; LIVER NEOPLASMS; RISK ASSESSMENT; ZEA MAYS;

EID: 84883148662     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft132     Document Type: Article

References (52)

1. Alavian, S. M., Tabatabaei, S. V., Ghadimi, T., Beedrapour, F., Kafi-Abad, S. A., Gharehbaghian, A., and Abolghasemi, H. (2012). Seroprevalence of Hepatitis B virus infection and its risk factors in the west of Iran: A population- based study. Int. J. Prev. Med. 3, 770-775.
2. Abdulrazzaq, Y. M., Osman, N., Yousif, Z. M., and Trad, O. (2004). Morbidity in neonates of mothers who have ingested aflatoxins. Ann. Trop. Paediatr. 24, 145-151.
3. André, F. (2000). Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18(Suppl. 1), S20-S22.
4. Bowers, J., Brown, B., Springer, J., Tollefson, L., Lorentzen, R., and Henry, S. (1993). Risk assessment for aflatoxin: An evaluation based on the multistage model. Risk Anal. 13, 637-642.
5. Ciccozzi, M., Babakir-Mina, M., Lo Presti, A., Salpini, R., Cella, E., Gabanelli, E., Teoharov, P., Kevorkyan, A., Perno, C. F., Zehender, G., et al. (2013). Molecular analysis of hepatitis B virus in Bulgaria. J. Med. Virol. 85, 49-54.
6. Cotty, P. J., Antilla, L., and Wakelyn, P. J. (2007). Competitive exclusion of aflatoxin producers: Farmer-driven research and development. In Biological Control: A Global Perspective, pp. 241-253. CABI, Cambridge, MA.
7. Dorner, J. W., and Horn, B. W. (2007). Separate and combined applications of nontoxigenic Aspergillus flavus and A. parasiticus for biocontrol of aflatoxin in peanuts. Mycopathologia 163, 215-223.
8. Eaton, D. L., and Gallagher, E. P. (1994). Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34, 135-172.
9. European Centre for Disease Control and Prevention (2010). Hepatitis B and C in the EU Neighborhood: Prevalence, Burden of Disease and Screening Policies. Available at: http://ecdc.europa.eu/en/healthtopics/hepatitis_B/Pages/index.aspx. Accessed November 30, 2012.
10. Food and Agriculture Organization (FAO) (2004).Worldwide Regulations for Mycotoxins in Food and Feed in 2003. Available at: http://www.fao.org/docrep/007/y5499e/y5499e00.HTM. Accessed February 3, 2013.
11. Gong, Y., Hounsa, A., Egal, S., Turner, P. C., Sutcliffe, A. E., Hall, A. J., Cardwell, K., and Wild, C. P. (2004). Postweaning exposure to aflatoxin results in impaired child growth: A longitudinal study in Benin, West Africa. Environ. Health Perspect. 112, 1334-1338.
12. Gong, Y. Y., Cardwell, K., Hounsa, A., Egal, S., Turner, P. C., Hall, A. J., and Wild, C. P. (2002). Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: Cross sectional study. BMJ. 325, 20-21.
13. Gong, Y. Y., Egal, S., Hounsa, A., Turner, P. C., Hall, A. J., Cardwell, K. F., and Wild, C. P. (2003). Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: The critical role of weaning. Int. J. Epidemiol. 32, 556-562.
14. Greim, H., and Albertini, R. (2012). The Cellular Response to the Genotoxic Insult: The Question of Threshold for Genotoxic Carcinogens. Royal Society of Chemistry, Cambridge, UK. ISBN:978-1-84973-177-5.
15. Groopman, J. D., Kensler, T. W., and Wild, C. P. (2008). Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public Health 29, 187-203.
16. Hannachi, N., Fredj, N. B., Bahri, O., Thibault, V., Ferjani, A., Gharbi, J., Triki, H., and Boukadida, J. (2010). Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol. J. 7, 302.
17. Henry, S. H., Bosch, F. X., Troxell, T. C., and Bolger, P. M. (1999). Policy forum: Public health. Reducing liver cancer-global control of aflatoxin. Science 286, 2453-2454.
18. Holbrook, C. C., Jr, Guo, B., Wilson, D. M., and Timper, P. (2006). The U.S. breeding program to develop peanut with drought tolerance and reduced aflatoxin contamination. In Proceedings of the International Conference on Groundnut Aflatoxin Management and Genomics, 5-9 November 2006, Guangzhou, China (Abstract).
19. Hwang, E. W., and Cheung, R. (2011). Global epidemiology of hepatitis B virus (HBV) infection. N. Am. J. Med. Sci. 4, 7-13.
20. International Agency for Research on Cancer (IARC) (2002). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr. Eval. Carcinog. Risks Hum. 82, 171-300.
21. Iarovoi, P., Rimis, C., Spinu, C., and Isac, M. (2008). Epidemiology of hepatitis B virus infection in the Republic of Moldova. J. Infect. Dev. Ctries. 2, 190-192.
22. Joint FAO/WHO Expert Committee on Food Additives (JECFA) (1998). Safety Evaluation of Certain Food Additives and Contaminants. WHO Food Additives Series 40. Available at: http://www.inchem.org/documents/jecfa/jecmono/v040je16.htm. Accessed February 4, 2013.
23. Jiang, Y., Jolly, P. E., Ellis, W. O., Wang, J. S., Phillips, T. D., and Williams, J. H. (2005). Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 17, 807-814.
24. Johnston, L., Saumtally, A., Corceal, S., Mahadoo, I., and Oodally, F. (2011). High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: Findings from a population size estimation and respondent driven sampling survey. Int. J. Drug Policy 22, 252-258.
25. Kensler, T. W., Qian, G. S., Chen, J. G., and Groopman, J. D. (2003). Translational strategies for cancer prevention in liver. Nat. Rev. Cancer 3, 321-329.
26. Kensler, T. W., Roebuck, B. D., Wogan, G. N., and Groopman, J. D. (2011). Aflatoxin: A 50-year odyssey of mechanistic and translational toxicology. Toxicol. Sci. 120(Suppl. 1), S28-S48.
27. Khlangwiset, P., Shephard, G. S., and Wu, F. (2011). Aflatoxins and growth impairment: A review. Crit. Rev. Toxicol. 41, 740-755.
28. Khlangwiset, P., and Wu, F. (2010). Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit. Contam. Part A. Chem. Anal. Control. Expo. Risk Assess. 27, 998-1014.
29. Liu, Y., Chang, C. C., Marsh, G. M., and Wu, F. (2012). Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer 48, 2125-2136.
30. Liu, Y., and Wu, F. (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ. Health Perspect. 118, 818-824.
31. Magdzik, W. W. (2000). Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 18(Suppl. 1), S13-S16.
32. Mahdavi, R., Nikniaz, L., Arefhosseini, S. R., and Vahed Jabbari, M. (2010). Determination of aflatoxin M(1) in breast milk samples in Tabriz-Iran. Matern. Child Health J. 14, 141-145.
33. Okoth, S. A., and Ohingo, M. (2004). Dietary aflatoxin exposure and impaired growth in young children from Kisumu District, Kenya: Cross sectional study. Afr. J. Health Sci. 11, 43-54.
34. Olinger, C. M., Lazouskaya, N. V., Eremin, V. F., and Muller, C. P. (2008). Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: Similarities with Russia and western European influences. Clin. Microbiol. Infect. 14, 575-581.
35. Petrovic, J., Salkic, N. N., Ahmetagic, S., Stojic, V., and Mott-Divkovic, S. (2011). Prevalence of chronic hepatitis B and hepatitis C among first time blood donors in Northeast Bosnia and Herzegovina: An estimate of prevalence in general population. Hepat. Mon. 11, 629-633.
36. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3, 3-10.
37. Sadeghi, N., Oveisi, M., Jannat, B., Hajimahmoodi, M., Bonyani, H., and Jannat, F. (2009). Incidence of aflatoxin M 1 in human breast milk in Tehran, Iran. Food Control 20, 75-78.
38. Samayoa, B., Anderson, M. R., Alonso Pacheco, K. P., Lee, C., Pittard, A., Soltren, A., Barrios Matos, I., and Arathoon, E. (2010). Seroprevalence of HIV, hepatitis B, and syphilis among pregnant women at the general hospital, Guatemala City, 2005-2009. J. Int. Assoc. Physicians AIDS Care (Chic). 9, 313-317.
39. Shephard, G. S. (2008). Risk assessment of aflatoxins in food in Africa. Food Addit. Contam. Part A. Chem. Anal. Control. Expo. Risk Assess. 25, 1246-1256.
40. Shrestha, S. M., and Shrestha, S. (2012). Chronic hepatitis B in Nepal: An Asian country with low prevalence of HBV infection. Trop. Gastroenterol. 33, 95-101.
41. Shuaib, F. M., Jolly, P. E., Ehiri, J. E., Yatich, N., Jiang, Y., Funkhouser, E., Person, S. D., Wilson, C., Ellis, W. O., Wang, J. S., et al. (2010). Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop. Med. Int. Health 15, 160-167.
42. Strosnider, H., Azziz-Baumgartner, E., Banziger, M., Bhat, R. V., Breiman, R., Brune, M. N., DeCock, K., Dilley, A., Groopman, J., Hell, K., et al. (2006). Workgroup report: Public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect. 114, 1898-1903.
43. Tanaka, J. (2000). Hepatitis B epidemiology in Latin America. Vaccine 18(Suppl. 1), S17-S19.
44. Turner, P. C., Collinson, A. C., Cheung, Y. B., Gong, Y., Hall, A. J., Prentice, A. M., and Wild, C. P. (2007). Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 36, 1119-1125.
45. Turner, P. C., Moore, S. E., Hall, A. J., Prentice, A. M., and Wild, C. P. (2003). Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111, 217-220.
46. Turner, P. C., Sylla, A., Gong, Y. Y., Diallo, M. S., Sutcliffe, A. E., Hall, A. J., and Wild, C. P. (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: A community-based intervention study. Lancet 365, 1950-1956.
47. World Health Organization (WHO) (2006). Global Environment Monitoring System-Food Contamination Monitoring and Assessment Programme (GEMS/Food). Available at: http://www.who.int/foodsafety/chem/gems/en/index1.html. Accessed November 28, 2012.
48. WHO (2013). Table of Prevalence of Hepatitis B in Various Areas. Available at: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index1.html#world. Accessed January 14, 2013.
49. Williams, J. H., Phillips, T. D., Jolly, P. E., Stiles, J. K., Jolly, C. M., and Aggarwal, D. (2004). Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 80, 1106-1122.
50. Wu, F., and Guclu, H. (2012). Aflatoxin regulations in a network of global maize trade. PLoS ONE 7, e45141. doi:10.1371/journal.pone.0045151
51. Wu, H. C., Wang, Q., Yang, H. I., Ahsan, H., Tsai, W. Y., Wang, L. Y., Chen, S. Y., Chen, C. J., and Santella, R. M. (2009). Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol. Biomarkers Prev. 18, 846-853.
52. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., and Henderson, B. E. (1989). Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49, 2506-2509.